Meisner Derek M.'s Insider Trades & SAST Disclosures
Meisner Derek M.'s most recent trade in Acumen Pharmaceuticals Inc was a trade of 3,418 Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on Jan. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Meisner Derek M..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acumen Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Officer & Corp Sec | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 21 Jan 2025 | 3,418 | 161,127 | - | 1.6 | 5,435 | Common Stock |
| Acumen Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Officer & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 100,300 | 100,300 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Officer & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 66,800 | 164,545 | - | 0 | Common Stock | |
| Acumen Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Officer & Corp Sec | Sale of securities on an exchange or to another person at price $ 1.84 per share. | 03 Jan 2025 | 11,122 | 97,745 | - | 1.8 | 20,506 | Common Stock |
| Acumen Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Officer & Corp Sec | Sale of securities on an exchange or to another person at price $ 3.48 per share. | 19 Jan 2024 | 8,933 | 108,867 | - | 3.5 | 31,048 | Common Stock |
| Acumen Pharmaceuticals Inc | M. Derek Meisner | Chief Legal Officer & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 137,000 | 137,000 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Meisner Derek M. | Chief Legal Officer & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 91,000 | 117,800 | - | 0 | Common Stock | |
| Acumen Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Office & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 120,800 | 120,800 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Office & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 26,800 | 26,800 | - | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 17 Aug 2022 | 8,334 | 145,155 (0%) | 0% | - | Common Stock | |
| X4 Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 24 Jun 2022 | 4,166 | 153,489 (0%) | 0% | - | Common Stock | |
| X4 Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Jun 2022 | 4,166 | 157,655 (0%) | 0% | - | Common Stock | |
| X4 Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 105,000 | 161,821 (1%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Derek M. Meisner | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Feb 2022 | 15,909 | 56,821 (0%) | 0% | - | Common Stock | |
| X4 Pharmaceuticals Inc | Derek M. Meisner | General Counsel | Sale of securities on an exchange or to another person at price $ 5.10 per share. | 17 Aug 2021 | 8,332 | 72,730 (0%) | 0% | 5.1 | 42,493 | Common Stock |
| X4 Pharmaceuticals Inc | Derek M. Meisner | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 12,500 | 85,228 (0%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Derek M. Meisner | General Counsel | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 23 Jun 2021 | 4,166 | 81,062 (0%) | 0% | 7 | 29,162 | Common Stock |
| X4 Pharmaceuticals Inc | Derek M. Meisner | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 12,500 | 76,894 (0%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Derek M. Meisner | General Counsel | Sale of securities on an exchange or to another person at price $ 7.84 per share. | 15 Jun 2021 | 4,166 | 72,728 (0%) | 0% | 7.8 | 32,661 | Common Stock |
| X4 Pharmaceuticals Inc | Derek M. Meisner | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 47,728 | 64,394 (0%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Derek M. Meisner | General Counsel | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 09 Sep 2020 | 8,334 | 16,666 (0%) | 0% | 8.1 | 67,089 | Common Stock |
| X4 Pharmaceuticals Inc | Derek M. Meisner | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2020 | 12,500 | 25,000 (0%) | 0% | 0 | Common Stock | |
| X4 Pharmaceuticals Inc | Derek M. Meisner | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2020 | 12,500 | 12,500 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges